Little is known about cell division in Clostridium difficile, a strict anaerobe that causes serious diarrheal diseases in people whose normal intestinal microbiome has been perturbed by treatment with broad-spectrum antibiotics. Here we identify and characterize a gene cluster encoding three cell division proteins found only in C. difficile and a small number of closely related bacteria. These proteins were named MldA, MldB, and MldC, for midcell localizing division proteins. MldA is predicted to be a membrane protein with coiled-coil domains and a peptidoglycan-binding SPOR domain. MldB and MldC are predicted to be cytoplasmic proteins; MldB has two predicted coiled-coil domains, but MldC lacks obvious conserved domains or sequence motifs. Mutants of mldA or mldB had morphological defects, including loss of rod shape (a curved cell phenotype) and inefficient separation of daughter cells (a chaining phenotype). Fusions of cyan fluorescent protein (CFP) to MldA, MldB, and MldC revealed that all three proteins localize sharply to the division site. This application of CFP was possible because we discovered that O 2 -dependent fluorescent proteins produced anaerobically can acquire fluorescence after cells are fixed with cross-linkers to preserve native patterns of protein localization. Mutants lacking the Mld proteins are severely attenuated for pathogenesis in a hamster model of C. difficile infection. Because all three Mld proteins are essentially unique to C. difficile, they might be exploited as targets for antibiotics that combat C. difficile without disrupting the intestinal microbiome.C lostridium difficile is a strictly anaerobic, Gram-positive, spore-forming bacterium that has become the leading cause of hospital-acquired diarrhea in developed countries. The annual impact of C. difficile infections in the United States has been estimated at 14,000 deaths and over $1 billion in excess medical costs (1). Both the severity and the frequency of C. difficile infections are increasing (2), and a recent report on the impact of antibiotic resistance classified the organism as an "urgent threat," the highest threat level (1).C. difficile infections typically occur in people who have been treated with antibiotics that disrupt the flora of the gastrointestinal tract (3, 4). Although C. difficile is resistant to many antibiotics, the infection usually resolves upon treatment with metronidazole or oral vancomycin (5). Unfortunately, disease recurs in ϳ20% of patients, and the prognosis for this cohort is poor (4, 6, 7). The high rate of recurrence has been attributed to germination of C. difficile spores after antibiotic therapy is ended but before restoration of the normal flora (2, 8). For this reason, there is interest in developing antibiotics that target C. difficile selectively and in treatments such as fecal transplants which work by restoring a healthy microbiome (4, 7, 9, 10).Here we describe a cluster of three genes found in C. difficile that is important for morphogenesis, cell division, and pathogenesis. W...